Hangzhou Leap Chem Co., Ltd. yog ib qho ntawm cov tuam txhab tshaj lij thiab cov chaw muag khoom ntawm fmoc-alpha-methyl-l-leucine丨cas 312624-65-0 hauv Suav teb. Txais tos rau cov lag luam wholesale bulk zoo tshuaj cov khoom ntawm kev sis tw nqi los ntawm peb lub hoobkas. Yog tias koj muaj lus nug txog kev pabcuam kev cai, thov koj xa email rau peb.
Specifications
| Qhov tsos: | Dawb khoom |
| Kev txheeb xyuas (los ntawm 1H-NMR, MS): | Qauv & MW |
| Purity (HPLC): | 97% min |
| ee (Chiral HPLC): | 97% min |
Daim ntawv thov
Fmoc-alpha-methyl-L-leucine feem ntau yog siv rau hauvsolid-phase peptide synthesis (SPPS)los tsim peptides thiab peptidomimetics nrog txhim kho kev tswj hwm kev tswj hwm thiab tiv thaiv cov enzymatic degradation. Nws yog qhov tseem ceeb tshwj xeeb hauv kev tsim qauvbioactive peptides, peptide-raws li tshuaj, thiab cov qauv analogsuas yuav tsum tau nce metabolic stability lossis txwv yooj. Cov - methyl pab pawg txhawb nqa kev tswj hwm cov txheej txheem theem nrab, xws li -helices lossis - tig, ua kom haum rau cov qauv- kev tshawb fawb kev sib raug zoo thiab kev tsim cov receptor- khi ligands. HauvKev tshawb fawb tshuaj thiab biochemical, nws ua haujlwm tseem ceeb hauv kev tsim kho peptides, enzyme inhibitors, thiab peptide-raws li biomaterials. Tsis tas li ntawd, nws yog siv nyob rau hauvcombinatorial chemistryrau kev tsim ntau lub tsev qiv ntawv peptide nrog tswj stereochemistry thiab txhim kho cov khoom siv tshuaj.
Cov txiaj ntsig
Cov txiaj ntsig ntawm Fmoc-alpha-methyl-L-leucine suav nrog nws lub peev xwmtxhim khu peptide stability, rigidity, thiab bioavailability. Lub -methyl hloov pauv txo cov kev hloov pauv hloov pauv, pab peptides tswj cov kev ua haujlwm tshwj xeeb thiab tiv thaiv cov enzymatic cleavage, uas txuas ntxiv lawv cov roj ntsha ib nrab- lub neej. Qhov no ua rau nws muaj txiaj ntsig rau kev txhim kho kom ruaj khov thiab muaj zog peptide-raws li kev kho mob. Pab pawg tiv thaiv Fmoc muabzoo heev compatibility nrog tus qauv SPPS raws tu qauv, ua kom muaj txiaj ntsig zoo thiab tshem tawm tau yooj yim nyob rau hauv cov xwm txheej me me yam tsis muaj kev cuam tshuam rau sab chains. Lub compound kuj txhawbrational tsim ntawm bioactive peptides, txhim kho lub hom phiaj binding affinity thiab selectivity los ntawm stabilizing xav conformations. Zuag qhia tag nrho, nws pab chemists ua tiav kev tswj hwm zoo dua ntawm peptide qauv thiab ua haujlwm thaum lub sijhawm sib txuas thiab kev loj hlob.
Xaus
Hauv cov ntsiab lus, Fmoc-alpha-methyl-L-leucine yog ib qho tseem ceeb Fmoc- tiv thaiv amino acid siv nyob rau hauv peptide synthesis los txhim kho cov qauv kev ruaj ntseg, tsis kam mus rau enzymatic degradation, thiab lom kev ua tau zoo. Nws -kev hloov kho methyl qhia txog kev nruj thiab kev tswj hwm, thaum pab pawg Fmoc ua kom muaj kev sib raug zoo nrog cov txheej txheem peptide synthesis automated. Cov yam ntxwv no ua rau nws muaj txiaj ntsig zoo hauv kev tsim kho siab -kev ua haujlwm kho mob peptides, enzyme inhibitors, thiab cov txheej txheem txheej txheem biomolecules rau kev tshawb fawb thiab kev siv tshuaj.
Cim npe nrov: fmoc-alpha-methyl-l-leucine丨cas 312624-65-0, Tuam Tshoj fmoc-alpha-methyl-l-leucine丨cas 312624-65-65 manufacturers, hoobkas
